Select for export Psychedelics: Science sabotaged by Social Media. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2023.109426 PubMed 36693562 Copy citation Copy BibTeX Unknown journal 2023-01-20 Sellers EM, Romach MK. Europe PMC Published psilocybin Safety Other More
Select for export Utility of preclinical models in the study of psilocybin - A comprehensive review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neubiorev.2023.105046 PubMed 36646257 Copy citation Copy BibTeX Unknown journal 2023-01-12 Pedicini M, Cordner ZA. Europe PMC Published psilocybin PharmacologyMechanism of ActionEmotional Processing Review Article More
Select for export Psychedelics for Patients With Cancer: A Comprehensive Literature Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/10600280221144055 PubMed 36635883 Copy citation Copy BibTeX Unknown journal 2023-01-11 White CM, Weisman N, Dalo J. Europe PMC Published psilocybin DepressionAnxietyMechanism of Action Randomized Controlled Trial More
Select for export Are psychedelics the answer to chronic pain: A review of current literature. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/papr.13203 PubMed 36597700 Copy citation Copy BibTeX Unknown journal 2023-01-10 Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP Europe PMC Published psilocybin AddictionEnd-of-Life DistressChronic Pain Randomized Controlled Trial More
Select for export The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ijms24021329 PubMed 36674849 Copy citation Copy BibTeX Unknown journal 2023-01-09 Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G Europe PMC Published psilocybinpsilocin DepressionPTSDOCD Review Article More
Select for export An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/10499091221147700 PubMed 36604312 Copy citation Copy BibTeX Unknown journal 2023-01-04 Baker KM, Ulrich CM, Meghani SH. Europe PMC Published psilocybin WellbeingSpiritualityMystical Experience Review Article More
Select for export Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221140004 PubMed 36588452 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-31 Jack E. Henningfield, Judy Ashworth, David J. Heal, Sharon L. Smith OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1568026623666230705151922 PubMed 37409550 Copy citation Copy BibTeX Unknown journal 2022-12-31 Ezeaka UC, Kim HJJ, Laprairie RB. Europe PMC Published psilocybinpsilocin DepressionAnxietyAddiction Review Article More
Select for export The Resurgence of Hallucinogen Drugs in Clinical Research. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.24875/ric.23000108 PubMed 37441761 Copy citation Copy BibTeX Unknown journal 2022-12-31 Rivera-García MT, Cruz SL. Europe PMC Published psilocin Receptor PharmacologyReview ArticleAnimal Study Review Article More
Select for export UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES. No abstract availability was recorded for this entry. Details PubMed 37992112 Copy citation Copy BibTeX Unknown journal 2022-12-31 Ahmed H, Mushahid H, Arshad T. Europe PMC Published psilocybin DepressionCancer Patients Other More
Select for export Is psilocybin an effective antidepressant and what is its Mechanism of action? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.xcrm.2022.100906 PubMed 36652915 Copy citation Copy BibTeX Unknown journal 2022-12-31 Mann JJ. Europe PMC Published psilocybin DepressionMechanism of ActionSafety Other More
Select for export Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.ijchp.2022.100349 PubMed 36605409 Copy citation Copy BibTeX International journal of clinical and health psychology: IJCHP 2022-12-31 Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V PubMed Published psilocybin Mechanism of ActionReceptor PharmacologyReview Article Clinical Trial More
Select for export Mini-review: The neurobiology of treating substance use disorders with classical psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fnins.2023.1156319 PubMed 37139521 Copy citation Copy BibTeX Frontiers in neuroscience 2022-12-31 Urban MM, Stingl MR, Meinhardt MW PubMed Published psilocybin AddictionNeuroplasticityMechanism of Action Review Article More
Select for export Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2022.2125467 PubMed 36127639 Copy citation Copy BibTeX Journal of psychoactive drugs 2022-12-31 Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ PubMed Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06297-0 PubMed 36564671 Copy citation Copy BibTeX Unknown journal 2022-12-23 Meccia J, Lopez J, Bagot RC. Europe PMC Published psilocybin DepressionNeuroplasticityBrain Imaging Review Article More
Select for export The varieties of psychedelic law. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109399 PubMed 36565855 Copy citation Copy BibTeX Unknown journal 2022-12-20 Marks M. Europe PMC Published psilocybin General Other More
Select for export Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109375 PubMed 36529260 Copy citation Copy BibTeX Unknown journal 2022-12-15 Heal DJ, Gosden J, Smith SL, Atterwill CK. Europe PMC Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1227/neu.0000000000002275 PubMed 36512813 Copy citation Copy BibTeX Unknown journal 2022-12-07 Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Psychedelic-Assisted Therapy for People with Eating Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11920-022-01394-5 PubMed 36374357 Copy citation Copy BibTeX Current psychiatry reports 2022-11-30 Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS PubMed Published psilocybin Eating DisordersMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Considerations in assessing the abuse potential of psychedelics during drug development. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109352 PubMed 36455646 Copy citation Copy BibTeX Unknown journal 2022-11-27 Calderon SN, Bonson KR, Reissig CJ, Lloyd JM, Galati S, Chiapperino D. Europe PMC Published psilocybin Receptor Pharmacology Other More